(RTTNews) - Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion shareholders will receive consideration equal to $11.25 per share consisting of $5.85 per share in cash and $5.40 per share in Clearwater Class A stock. Clearwater is expected to pay a total of approximately $760 million in cash and issue between approximately 23 million and 28 million new shares to Enfusion shareholders. Also, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement. This equates to a purchase price of approximately $1.5 billion.
Clearwater said the acquisition of Enfusion accelerates Clearwater's vision of building the first cloud-native front-to-back platform for the entire investment management industry.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
